Last updated: 8 August 2024 at 7:21pm EST

Thomas Burns Net Worth




The estimated Net Worth of Thomas William Burns is at least $33.3 Million dollars as of 8 January 2024. Mr. Burns owns over 60,115 units of Glaukos stock worth over $7,021,725 and over the last 9 years he sold GKOS stock worth over $20,608,190. In addition, he makes $5,716,560 as President, Chief Executive Officer, and Director at Glaukos.

Mr. Burns GKOS stock SEC Form 4 insiders trading

Thomas has made over 44 trades of the Glaukos stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 60,115 units of GKOS stock worth $437,637 on 8 January 2024.

The largest trade he's ever made was exercising 286,880 units of Glaukos stock on 6 August 2021 worth over $1,273,747. On average, Thomas trades about 24,743 units every 33 days since 2015. As of 8 January 2024 he still owns at least 55,950 units of Glaukos stock.

You can see the complete history of Mr. Burns stock trades at the bottom of the page.





Thomas Burns biography

Thomas William Burns serves as President, Chief Executive Officer, Director of the Company. Mr. Burns has also been a member of the board of directors of DOSE Medical Corporation, serving as its chairman of the board, since October 2009 and served as its chief executive officer and president from March 2010 until June 2015. Mr. Burns has a proven record of building successful medical device and pharmaceutical businesses and creating successful new markets in ophthalmology. Mr. Burns has more than 25 years of direct ophthalmic management experience, including over 20 years of general management experience across a broad range of ophthalmic medical devices, ophthalmic pharmaceuticals, drug delivery technologies, surgical products and over-the-counter products. Prior to joining our Company, Mr. Burns led Eyetech Pharmaceuticals, Inc. (acquired by OSI Pharmaceuticals, Inc.) as its president and chief operating officer, and as a director. From 1990 to 1997, Mr. Burns served as senior vice president and general manager of Chiron Vision Corporation (acquired by Bausch & Lomb, Inc.), and then as vice president, global strategy and general manager, refractive surgery, of Bausch & Lomb from 1998 to 2000. Mr. Burns has also served as an entrepreneur in residence at Versant Ventures Management, LLC. Mr. Burns received a B.A. from Yale University. Mr. Burns currently serves as a director and as the chair of the compensation committee on the board of Avedro, Inc. (Nasdaq: AVDR).agreement terminated in its entirety upon the closing of our initial public offering.

What is the salary of Thomas Burns?

As the President, Chief Executive Officer, and Director of Glaukos, the total compensation of Thomas Burns at Glaukos is $5,716,560. There are no executives at Glaukos getting paid more.



How old is Thomas Burns?

Thomas Burns is 59, he's been the President, Chief Executive Officer, and Director of Glaukos since 2002. There are 5 older and 5 younger executives at Glaukos. The oldest executive at Glaukos Corporation is William Link, 74, who is the Independent Chairman of the Board.

What's Thomas Burns's mailing address?

Thomas's mailing address filed with the SEC is C/O GLAUKOS CORPORATION, ONE GLAUKOS WAY, ALISO VIEJO, CA, 92656.

Insiders trading at Glaukos

Over the last 11 years, insiders at Glaukos have traded over $300,254,118 worth of Glaukos stock and bought 17,376 units worth $317,262 . The most active insiders traders include Advisors Llc Orbi Med Capit..., Gilbert H Kliman, and Jonathan Silverstein. On average, Glaukos executives and independent directors trade stock every 25 days with the average trade being worth of $8,240,079. The most recent stock trade was executed by Gilbert H Kliman on 9 September 2024, trading 3,000 units of GKOS stock currently worth $96,000.



What does Glaukos do?

glaukos corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world’s leading causes of blindness. glaukos has pioneered micro-invasive glaucoma surgery, or migs, to revolutionize the traditional glaucoma treatment and management paradigm. the company launched the istent trabecular micro-bypass stent, its first migs device, in the united states in 2012. glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. glaukos believes the istent is the smallest medical device ever approved by the food and drug administration, or fda, measuring 1.0 mm long and 0.33 mm wide. in june 2015, the company completed an initial public offering and its shares are now traded on the new york stock exchange unde



What does Glaukos's logo look like?

Glaukos Corporation logo

Complete history of Mr. Burns stock trades at Glaukos and Pulmonx Corp

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
8 Jan 2024 Thomas William Burns
Chairman and CEO
Option 60,115 $7.28 $437,637
8 Jan 2024
55,950
2 Jan 2024 Thomas William Burns
Chairman and CEO
Option 95,000 $7.28 $691,600
2 Jan 2024
150,835
21 Dec 2023 Thomas William Burns
Chairman and CEO
Option 79,685 $7.28 $580,107
21 Dec 2023
55,836
14 Dec 2023 Thomas William Burns
Chairman and CEO
Option 90,000 $7.28 $655,200
14 Dec 2023
115,835
2 Oct 2023 Thomas William Burns
Chairman and CEO
Option 45,000 $7.28 $327,600
2 Oct 2023
99,785
19 Jul 2023 Thomas William Burns
Chairman and CEO
Option 200 $7.28 $1,456
19 Jul 2023
674,163
14 Jul 2023 Thomas William Burns
Chairman and CEO
Option 30,000 $7.28 $218,400
14 Jul 2023
703,963
7 Jul 2023 Thomas William Burns
Chairman and CEO
Option 13,573 $7.28 $98,811
7 Jul 2023
687,403
3 Jul 2023 Thomas William Burns
Chairman and CEO
Option 31,427 $7.28 $228,789
3 Jul 2023
678,990
28 Jun 2023 Thomas William Burns
Chairman and CEO
Option 26,810 $7.28 $195,177
28 Jun 2023
700,773
8 Jun 2023 Thomas William Burns
Chairman and CEO
Option 3,190 $7.28 $23,223
8 Jun 2023
677,153
6 Jun 2023 Thomas William Burns
Chairman and CEO
Option 25,000 $7.28 $182,000
6 Jun 2023
691,345
2 Jun 2023 Thomas William Burns
Chairman and CEO
Option 142 $7.28 $1,034
2 Jun 2023
674,105
19 May 2023 Thomas William Burns
Chairman and CEO
Option 8 $7.28 $58
19 May 2023
673,970
17 May 2023 Thomas William Burns
Chairman and CEO
Option 12,282 $7.28 $89,413
17 May 2023
685,625
15 May 2023 Thomas William Burns
Chairman and CEO
Option 7,568 $7.28 $55,095
15 May 2023
677,667
6 Aug 2021 Thomas William Burns
Chairman and CEO
Option 286,880 $4.44 $1,273,747
6 Aug 2021
635,062
26 May 2020 Thomas William Burns
Chairman and CEO
Option 207,447 $3.98 $825,639
26 May 2020
513,336
20 May 2020 Thomas William Burns
Chairman and CEO
Option 400 $3.98 $1,592
20 May 2020
306,289
28 Feb 2020 Thomas William Burns
Chairman and CEO
Option 212,596 $5.59 $1,188,412
28 Feb 2020
272,499
20 Dec 2019 Thomas William Burns
Chairman and CEO
Option 10,000 $3.98 $39,800
20 Dec 2019
58,807
9 Dec 2019 Thomas William Burns
Chairman and CEO
Option 3,583 $3.70 $13,257
9 Dec 2019
48,807
6 Aug 2018 Thomas William Burns
Chairman and CEO
Option 150,000 $1.95 $292,500
6 Aug 2018
328,355
26 Jan 2018 Thomas William Burns
Chairman and CEO
Option 47,000 $1.25 $58,750
26 Jan 2018
277,240
27 Dec 2017 Thomas William Burns
Chairman and CEO
Option 20,000 $1.25 $25,000
27 Dec 2017
230,240
7 Sep 2017 Thomas William Burns
Chairman and CEO
Option 73,788 $1.70 $125,440
7 Sep 2017
284,028
5 Sep 2017 Thomas William Burns
Chairman and CEO
Option 1,212 $1.93 $2,339
5 Sep 2017
211,452
2 Feb 2017 Thomas William Burns
Chairman and CEO
Sale 50,000 $42.58 $2,129,000
2 Feb 2017
210,240
9 Jan 2017 Thomas William Burns
Chairman and CEO
Sale 40,000 $37.60 $1,504,000
9 Jan 2017
260,240
14 Dec 2016 Thomas William Burns
Chairman and CEO
Option 8,000 $1.25 $10,000
14 Dec 2016
299,388
14 Nov 2016 Thomas William Burns
Chairman and CEO
Sale 200,120 $33.68 $6,740,042
14 Nov 2016
290,000
12 Jul 2016 Thomas William Burns
Chairman and CEO
Sale 162,254 $30.07 $4,878,978
12 Jul 2016
300,000
1 Jul 2016 Thomas William Burns
Chairman and CEO
Sale 50,000 $29.12 $1,456,000
1 Jul 2016
462,254
20 Jun 2016 Thomas William Burns
Chairman and CEO
Sale 7,997 $30.00 $239,910
20 Jun 2016
512,254
6 Jun 2016 Thomas William Burns
Chairman and CEO
Sale 24,578 $25.16 $618,382
6 Jun 2016
520,251
3 Jun 2016 Thomas William Burns
Chairman and CEO
Sale 422 $25.00 $10,550
3 Jun 2016
544,829
3 Jun 2016 Thomas William Burns
Chairman and CEO
Sale 422 $25.00 $10,550
3 Jun 2016
544,829
1 Jun 2016 Thomas William Burns
Chairman and CEO
Sale 25,000 $23.90 $597,500
1 Jun 2016
545,251
1 Jun 2016 Thomas William Burns
Chairman and CEO
Sale 25,000 $23.90 $597,500
1 Jun 2016
545,251
25 May 2016 Thomas William Burns
Chairman and CEO
Sale 300 $25.00 $7,500
25 May 2016
570,251
25 May 2016 Thomas William Burns
Chairman and CEO
Sale 300 $25.00 $7,500
25 May 2016
570,251
3 May 2016 Thomas William Burns
Chairman and CEO
Sale 36,700 $24.67 $905,389
3 May 2016
570,551
3 May 2016 Thomas William Burns
Chairman and CEO
Sale 36,700 $24.67 $905,389
3 May 2016
570,551
31 Dec 2015 Thomas William Burns
Chairman and CEO
Buy 1,388 $15.30 $21,236
31 Dec 2015
1,388


Glaukos executives and stock owners

Glaukos executives and other stock owners filed with the SEC include: